Video | 15 February 2020 A recipe for an affordable medicine goes bad 1 min RESEARCH AND DEVELOPMENT Governments use taxpayer money to try to get Big Pharma to develop medicines we need. These incentives are supposed to be the ingredients for an affordable medicine. Watch the video to see how it really turns out. Share this message! Tell your leaders: We won’t pay twice for medicines any more. Share on Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Photograph by Alexandra Sadokova Press release Press release | 25 April 2024 Transparency Research and development Tuberculosis In precedent-setting move towards drug-development cost transparency, MSF reveals cost of its landmark TB clinical trial: €34 million 6 min Technical brief | 25 April 2024 Transparency Research and development Transparency CORE: Clinical Trial Cost Reporting Toolkit Technical brief | 17 July 2023 Pandemic preparedness Intellectual property and trade Research and development MSF Position Paper: Ensuring Timely and Equitable Access to Medical Products in Global Public Health Emergencies Technical brief | 22 May 2023 Research and development Roundtable: Disclosing Clinical Trial Costs – Why and How Should It Be Done? Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min Events Events | 17 November 2022 Research and development How can disclosing clinical trial costs increase access to medical products? Load More
Photograph by Alexandra Sadokova Press release Press release | 25 April 2024 Transparency Research and development Tuberculosis In precedent-setting move towards drug-development cost transparency, MSF reveals cost of its landmark TB clinical trial: €34 million 6 min
Technical brief | 25 April 2024 Transparency Research and development Transparency CORE: Clinical Trial Cost Reporting Toolkit
Technical brief | 17 July 2023 Pandemic preparedness Intellectual property and trade Research and development MSF Position Paper: Ensuring Timely and Equitable Access to Medical Products in Global Public Health Emergencies
Technical brief | 22 May 2023 Research and development Roundtable: Disclosing Clinical Trial Costs – Why and How Should It Be Done?
Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min
Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min
Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min
Events Events | 17 November 2022 Research and development How can disclosing clinical trial costs increase access to medical products?